Sphingolipid metabolites have recently been shown to regulate a wide variety of cellular processes, including cell growth, differentiation and apoptosis. Recently we discovered that the orphan receptor endothelial differentiation gene-1 (Edg-1) is the receptor for sphingosine-1-phosphate (SPP). Edg-1 is coupled through a Gi protein to cause decreased cAMP and activation of the MAP kinase ERK2. SPP signaling through Edg-1 causes morphological changes resembling differentiation of endothelial cells in vitro, through a mechanism which requires the small GTPase Rho. The long-term objectives of this project are to determine the binding site for SPP on Edg-1, and how Edg-1 signaling regulates gene expression. These goals will be addressed by using site-directed mutagenesis to determine which of several candidate residues of Edg-1 may be involved in binding SPP. The effects of these mutations on SPP binding and on Edg-1 signaling will be determined. In addition, gene expression regulated by the serum response element (SRE) promoter will be examined. The SRE regulates transcription of several early response genes including c-fos, expression of which is regulated by SPP in some cell types. SPP / Edg-1-induced gene transcription will be measured using reporter plasmids regulated by the wild type or a mutant SRE, which can discriminate between Rho-mediated and MAP kinase- mediated signaling pathways, in order to elucidate the mechanisms used by Edg-1 to regulate this important promoter. Dominant negative mutants of the small GTPase Rho and the kinase Raf-1 will also be used to specifically block Rho- and MAP kinase- mediated signaling respectively, in order to define the role of these pathways in Edg-1 regulated gene expression.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32GM019209-02
Application #
6018364
Study Section
Biological Sciences 2 (BIOL)
Project Start
1998-07-01
Project End
Budget Start
1999-07-01
Budget End
1999-07-31
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Georgetown University
Department
Biochemistry
Type
Schools of Dentistry
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Orlati, S; Porcelli, A M; Hrelia, S et al. (2000) Sphingosine-1-phosphate activates phospholipase D in human airway epithelial cells via a G protein-coupled receptor. Arch Biochem Biophys 375:69-77
Van Brocklyn, J R; Graler, M H; Bernhardt, G et al. (2000) Sphingosine-1-phosphate is a ligand for the G protein-coupled receptor EDG-6. Blood 95:2624-9
Wang, F; Van Brocklyn, J R; Hobson, J P et al. (1999) Sphingosine 1-phosphate stimulates cell migration through a G(i)-coupled cell surface receptor. Potential involvement in angiogenesis. J Biol Chem 274:35343-50
Van Brocklyn, J R; Tu, Z; Edsall, L C et al. (1999) Sphingosine 1-phosphate-induced cell rounding and neurite retraction are mediated by the G protein-coupled receptor H218. J Biol Chem 274:4626-32
Wang, F; Van Brocklyn, J R; Edsall, L et al. (1999) Sphingosine-1-phosphate inhibits motility of human breast cancer cells independently of cell surface receptors. Cancer Res 59:6185-91